Atrial Fibrillation Trial To Eliminate Risk-factors
AFTTER
1 other identifier
observational
343
1 country
1
Brief Summary
The goal of this prospective-enrolling cohort study is to test and observe the effect of an integrated multi-discipline care program in patients with atrial fibrillation. The main questions it aims to answer are:
- 1.to understand the baseline characteristics and to explore the occult risk factors of the patients with AF;
- 2.to monitor the treatment efficacy of the patients undergoing integrated care and potentially concur the clinical obstacles that prevent the best care for patients with AF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 30, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedJanuary 16, 2026
January 1, 2026
4.3 years
January 30, 2023
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
AF burden
The duration in AF on 14-day ECG monitor (percent)
0~24 months
Secondary Outcomes (1)
MACE, major adverse cardiovascular event
0~24 months
Interventions
multi-discipline care program
Eligibility Criteria
Adult patients with documented atrial fibrillation, either paroxysmal, persistent, or permanent.
You may qualify if:
- At least 18 years old, who have been diagnosed with atrial fibrillation by a cardiologist with an electrocardiogram
You may not qualify if:
- Unable to complete the initial assessment and cooperate with the tracker
- Those who refuse to sign the subject's consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospita
Taipei, 100, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chih-Chieh Yu, MD.PhD
National Taiwan University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2023
First Posted
February 8, 2023
Study Start
May 1, 2020
Primary Completion
August 5, 2024
Study Completion
August 31, 2024
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share